Market Cap

Myovant Sciences Ltd. Market Capitalization:

$2.61 Billion

USD as of Jan. 1, 2023

business Myovant Sciences Ltd. Company Profile

Myovant Sciences Ltd. Main Stock Listing

NYSE: MYOV

Market Capitalization History of Myovant Sciences Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Myovant Sciences Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2023 $2.61 B 106.16%
Jan. 1, 2022 $1.27 B -43.92%
Jan. 1, 2021 $2.26 B 83.39%
Jan. 1, 2020 $1.23 B -31.13%
Jan. 1, 2019 $1.79 B 31.90%
Jan. 1, 2018 $1.35 B 25.49%
Jan. 1, 2017 $1.08 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +298.72%

$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Myovant Sciences Ltd. Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

Myovant Sciences Ltd. has the following listings and related stock indices.


Stock: NYSE: MYOV

Stock: FSX: 71M

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.